Literature DB >> 9435274

The sensitivity of the human Kv1.3 (hKv1.3) lymphocyte K+ channel to regulation by PKA and PKC is partially lost in HEK 293 host cells.

J Martel1, G Dupuis, P Deschênes, M D Payet.   

Abstract

cDNA encoding the full-length hKv1.3 lymphocyte channel and a C-terminal truncated (delta 459-523) form that lacks the putative PKA Ser468 phosphorylation site were stably transfected in human embryonic kidney (HEK) 293 cells. Immunostaining of the transfected cells revealed a distribution at the plasma membrane that was uniform in the case of the full-length channel whereas clustering was observed in the case of the truncated channel. Some straining within the cell cytoplasm was found in both instances, suggesting an active process of biosynthesis. Analyses of the K+ current by the patch-clamp technique in the whole cell configuration showed that depolarizing steps to 40 mV from a holding potential (HP) of -80 mV elicited an outward current of 2 to 10 nA. The current threshold was positive to -40 mV and the current amplitude increased in a voltage-dependent manner. The parameters of activation were -5.7 and -9.9 mV (slope factor) and -35 mV (half activation, V0.5) in the case of the full-length and truncated channels, respectively. The characteristics of the inactivation were 14.2 and 24.6 mV (slope factor) and -17.3 and -39.0 mV (V0.5) for the full-length and truncated channels, respectively. The activation time constant of the full-length channel for potentials ranging from -30 to 40 mV decreased from 18 to 12 msec whereas the inactivation time constant decreased from 6600 msec at -30 mV to 1800 msec at 40 mV. The unit current amplitude measured in cells bathing in 140 mM KCl was 1.3 +/- 0.1 pA at 40 mV, the unit conductance, 34.5 pS and the zero current voltage, 0 mV. Both forms of the channels were inhibited by TEA, 4-AP, Ni2+ and charybdotoxin. In contrast to the native (Jurkat) lymphocyte Kv1.3 channel that is fully inhibited by PKA and PKC, the addition of TPA resulted in 34.6 +/- 7.3% and 38.7 +/- 9.4% inhibition of the full-length and the truncated channels, respectively, 8-BrcAMP induced a 39.4 +/- 5.4% inhibition of the full-length channel but had no effect (8.6 +/- 8.3%) on the truncated channel. Cell dialysis with alkaline phosphatase had no effects, suggesting that the decreased sensitivity of the transfected channels to PKA and PKC was not due to an already phosphorylated channel. Patch extract experiments suggested that the hKv1.3 channel was partially sensitive to PKA and PKC. Cotransfecting the Kv beta 1.2 subunit resulted in a decrease in the value of the time constant of inactivation of the full-length channel but did not modify its sensitivity to PKA and PKC. The cotransfected Kv beta 2 subunit had no effects. Our results indicate that the hKv1.3 lymphocyte channel retains its electrophysiological characteristics when transfected in the Kv beta-negative HEK 293 cell line but its sensitivity to modulation by PKA and PKC is significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435274     DOI: 10.1007/s002329900325

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  12 in total

1.  Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current.

Authors:  Kevin S Thorneloe; Mark T Nelson
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

2.  Detection of channel proximity by nanoparticle-assisted delaying of toxin binding; a combined patch-clamp and flow cytometric energy transfer study.

Authors:  Bálint Rubovszky; Péter Hajdú; Zoltán Krasznai; Rezsõ Gáspár; Thomas A Waldmann; Sándor Damjanovich; László Bene
Journal:  Eur Biophys J       Date:  2005-03       Impact factor: 1.733

Review 3.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

4.  Kv1.5 association modifies Kv1.3 traffic and membrane localization.

Authors:  Rubén Vicente; Núria Villalonga; Maria Calvo; Artur Escalada; Carles Solsona; Concepció Soler; Michael M Tamkun; Antonio Felipe
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

5.  Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.

Authors:  Elyssa D Burg; Oleksandr Platoshyn; Igor F Tsigelny; Beatriz Lozano-Ruiz; Brinda K Rana; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

6.  Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex.

Authors:  Zerrin Kuras; Vladimir Kucher; Scott M Gordon; Lisa Neumeier; Ameet A Chimote; Alexandra H Filipovich; Laura Conforti
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

7.  Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.

Authors:  Shigeru Shibata; Juan Pablo Arroyo; María Castañeda-Bueno; Jeremy Puthumana; Junhui Zhang; Shunya Uchida; Kathryn L Stone; TuKiet T Lam; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

8.  Molecular determinants of cAMP-mediated regulation of the Na+-Ca2+ exchanger expressed in human cell lines.

Authors:  Li-Ping He; L Cleemann; N M Soldatov; M Morad
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

9.  Glucose sensitivity of mouse olfactory bulb neurons is conveyed by a voltage-gated potassium channel.

Authors:  Kristal Tucker; Sukhee Cho; Nicolas Thiebaud; Michael X Henderson; Debra Ann Fadool
Journal:  J Physiol       Date:  2013-03-11       Impact factor: 5.182

10.  Localization of Kv1.3 channels in the immunological synapse modulates the calcium response to antigen stimulation in T lymphocytes.

Authors:  Stella A Nicolaou; Lisa Neumeier; Ashleigh Steckly; Vladimir Kucher; Koichi Takimoto; Laura Conforti
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.